Cargando…

The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China

BACKGROUND: Reaching optimal vaccination rates is an essential public health strategy to control the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to simulate the optimal vaccination strategy to control the disease by developing an age-specific model based on the current transmissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ze-yu, Niu, Yan, Luo, Li, Hu, Qing-qing, Yang, Tian-long, Chu, Mei-jie, Chen, Qiu-ping, Lei, Zhao, Rui, Jia, Song, Cheng-long, Lin, Sheng-nan, Wang, Yao, Xu, Jing-wen, Zhu, Yuan-zhao, Liu, Xing-chun, Yang, Meng, Huang, Jie-feng, Liu, Wei-kang, Deng, Bin, Liu, Chan, Li, Zhuo-yang, Li, Pei-hua, Su, Yan-hua, Zhao, Ben-hua, Huang, Wen-long, Frutos, Roger, Chen, Tian-mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712277/
https://www.ncbi.nlm.nih.gov/pubmed/34963481
http://dx.doi.org/10.1186/s40249-021-00922-4
_version_ 1784623532827738112
author Zhao, Ze-yu
Niu, Yan
Luo, Li
Hu, Qing-qing
Yang, Tian-long
Chu, Mei-jie
Chen, Qiu-ping
Lei, Zhao
Rui, Jia
Song, Cheng-long
Lin, Sheng-nan
Wang, Yao
Xu, Jing-wen
Zhu, Yuan-zhao
Liu, Xing-chun
Yang, Meng
Huang, Jie-feng
Liu, Wei-kang
Deng, Bin
Liu, Chan
Li, Zhuo-yang
Li, Pei-hua
Su, Yan-hua
Zhao, Ben-hua
Huang, Wen-long
Frutos, Roger
Chen, Tian-mu
author_facet Zhao, Ze-yu
Niu, Yan
Luo, Li
Hu, Qing-qing
Yang, Tian-long
Chu, Mei-jie
Chen, Qiu-ping
Lei, Zhao
Rui, Jia
Song, Cheng-long
Lin, Sheng-nan
Wang, Yao
Xu, Jing-wen
Zhu, Yuan-zhao
Liu, Xing-chun
Yang, Meng
Huang, Jie-feng
Liu, Wei-kang
Deng, Bin
Liu, Chan
Li, Zhuo-yang
Li, Pei-hua
Su, Yan-hua
Zhao, Ben-hua
Huang, Wen-long
Frutos, Roger
Chen, Tian-mu
author_sort Zhao, Ze-yu
collection PubMed
description BACKGROUND: Reaching optimal vaccination rates is an essential public health strategy to control the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to simulate the optimal vaccination strategy to control the disease by developing an age-specific model based on the current transmission patterns of COVID-19 in Wuhan City, China. METHODS: We collected two indicators of COVID-19, including illness onset data and age of confirmed case in Wuhan City, from December 2, 2019, to March 16, 2020. The reported cases were divided into four age groups: group 1, ≤ 14 years old; group 2, 15 to 44 years old; group 3, 44 to 64 years old; and group 4, ≥ 65 years old. An age-specific susceptible-exposed-symptomatic-asymptomatic-recovered/removed model was developed to estimate the transmissibility and simulate the optimal vaccination strategy. The effective reproduction number (R(eff)) was used to estimate the transmission interaction in different age groups. RESULTS: A total of 47 722 new cases were reported in Wuhan City from December 2, 2019, to March 16, 2020. Before the travel ban of Wuhan City, the highest transmissibility was observed among age group 2 (R(eff) = 4.28), followed by group 2 to 3 (R(eff) = 2.61), and group 2 to 4 (R(eff) = 1.69). China should vaccinate at least 85% of the total population to interrupt transmission. The priority for controlling transmission should be to vaccinate 5% to 8% of individuals in age group 2 per day (ultimately vaccinated 90% of age group 2), followed by 10% of age group 3 per day (ultimately vaccinated 90% age group 3). However, the optimal vaccination strategy for reducing the disease severity identified individuals ≥ 65 years old as a priority group, followed by those 45–64 years old. CONCLUSIONS: Approximately 85% of the total population (nearly 1.2 billion people) should be vaccinated to build an immune barrier in China to safely consider removing border restrictions. Based on these results, we concluded that 90% of adults aged 15–64 years should first be vaccinated to prevent transmission in China. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-021-00922-4.
format Online
Article
Text
id pubmed-8712277
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87122772021-12-28 The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China Zhao, Ze-yu Niu, Yan Luo, Li Hu, Qing-qing Yang, Tian-long Chu, Mei-jie Chen, Qiu-ping Lei, Zhao Rui, Jia Song, Cheng-long Lin, Sheng-nan Wang, Yao Xu, Jing-wen Zhu, Yuan-zhao Liu, Xing-chun Yang, Meng Huang, Jie-feng Liu, Wei-kang Deng, Bin Liu, Chan Li, Zhuo-yang Li, Pei-hua Su, Yan-hua Zhao, Ben-hua Huang, Wen-long Frutos, Roger Chen, Tian-mu Infect Dis Poverty Research Article BACKGROUND: Reaching optimal vaccination rates is an essential public health strategy to control the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to simulate the optimal vaccination strategy to control the disease by developing an age-specific model based on the current transmission patterns of COVID-19 in Wuhan City, China. METHODS: We collected two indicators of COVID-19, including illness onset data and age of confirmed case in Wuhan City, from December 2, 2019, to March 16, 2020. The reported cases were divided into four age groups: group 1, ≤ 14 years old; group 2, 15 to 44 years old; group 3, 44 to 64 years old; and group 4, ≥ 65 years old. An age-specific susceptible-exposed-symptomatic-asymptomatic-recovered/removed model was developed to estimate the transmissibility and simulate the optimal vaccination strategy. The effective reproduction number (R(eff)) was used to estimate the transmission interaction in different age groups. RESULTS: A total of 47 722 new cases were reported in Wuhan City from December 2, 2019, to March 16, 2020. Before the travel ban of Wuhan City, the highest transmissibility was observed among age group 2 (R(eff) = 4.28), followed by group 2 to 3 (R(eff) = 2.61), and group 2 to 4 (R(eff) = 1.69). China should vaccinate at least 85% of the total population to interrupt transmission. The priority for controlling transmission should be to vaccinate 5% to 8% of individuals in age group 2 per day (ultimately vaccinated 90% of age group 2), followed by 10% of age group 3 per day (ultimately vaccinated 90% age group 3). However, the optimal vaccination strategy for reducing the disease severity identified individuals ≥ 65 years old as a priority group, followed by those 45–64 years old. CONCLUSIONS: Approximately 85% of the total population (nearly 1.2 billion people) should be vaccinated to build an immune barrier in China to safely consider removing border restrictions. Based on these results, we concluded that 90% of adults aged 15–64 years should first be vaccinated to prevent transmission in China. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40249-021-00922-4. BioMed Central 2021-12-28 /pmc/articles/PMC8712277/ /pubmed/34963481 http://dx.doi.org/10.1186/s40249-021-00922-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Zhao, Ze-yu
Niu, Yan
Luo, Li
Hu, Qing-qing
Yang, Tian-long
Chu, Mei-jie
Chen, Qiu-ping
Lei, Zhao
Rui, Jia
Song, Cheng-long
Lin, Sheng-nan
Wang, Yao
Xu, Jing-wen
Zhu, Yuan-zhao
Liu, Xing-chun
Yang, Meng
Huang, Jie-feng
Liu, Wei-kang
Deng, Bin
Liu, Chan
Li, Zhuo-yang
Li, Pei-hua
Su, Yan-hua
Zhao, Ben-hua
Huang, Wen-long
Frutos, Roger
Chen, Tian-mu
The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China
title The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China
title_full The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China
title_fullStr The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China
title_full_unstemmed The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China
title_short The optimal vaccination strategy to control COVID-19: a modeling study in Wuhan City, China
title_sort optimal vaccination strategy to control covid-19: a modeling study in wuhan city, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712277/
https://www.ncbi.nlm.nih.gov/pubmed/34963481
http://dx.doi.org/10.1186/s40249-021-00922-4
work_keys_str_mv AT zhaozeyu theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT niuyan theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT luoli theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT huqingqing theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT yangtianlong theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT chumeijie theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT chenqiuping theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT leizhao theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT ruijia theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT songchenglong theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT linshengnan theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT wangyao theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT xujingwen theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT zhuyuanzhao theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT liuxingchun theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT yangmeng theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT huangjiefeng theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT liuweikang theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT dengbin theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT liuchan theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT lizhuoyang theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT lipeihua theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT suyanhua theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT zhaobenhua theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT huangwenlong theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT frutosroger theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT chentianmu theoptimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT zhaozeyu optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT niuyan optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT luoli optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT huqingqing optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT yangtianlong optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT chumeijie optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT chenqiuping optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT leizhao optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT ruijia optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT songchenglong optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT linshengnan optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT wangyao optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT xujingwen optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT zhuyuanzhao optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT liuxingchun optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT yangmeng optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT huangjiefeng optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT liuweikang optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT dengbin optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT liuchan optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT lizhuoyang optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT lipeihua optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT suyanhua optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT zhaobenhua optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT huangwenlong optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT frutosroger optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina
AT chentianmu optimalvaccinationstrategytocontrolcovid19amodelingstudyinwuhancitychina